Philip Morris International (PM) Q3 2026: Adjusted EPS Growth Amid Currency Headwinds — Positive Outlook: Slides 6.4% at Open — Post-Earnings Analysis

Philip Morris International Inc. (PMI) reported its third-quarter results for 2026, showcasing a mixed performance with notable growth in adjusted earnings per share (EPS) but a decline in reported EPS. The company’s reported diluted EPS fell by 4.9% to $2.12, while adjusted diluted EPS increased by 5.4% to $2.36, reflecting a strong operational performance despite currency fluctuations.

Key Financial Metrics

• Reported Diluted EPS: $2.12, down from $2.23 in Q3 2025 (a decline of 4.9%).
• Adjusted Diluted EPS: $2.36, up from $2.24 in Q3 2025 (an increase of 5.4%).
• Net Revenues: $11.4 billion, an increase of 5.5% (7.1% organically) compared to Q3 2025.
• Gross Profit: $7.9 billion, up 6.7% (8.3% organically) year-over-year.
• Operating Income: Increased by 14.1% (10.5% organically) to $4.9 billion.

Analyst View

This quarter can be viewed positively for shareholders, primarily due to the growth in adjusted EPS and strong revenue performance. The adjusted EPS growth of 5.4% indicates that the core business is performing well, particularly in the smoke-free product segment, which now accounts for over 40% of total net revenues. The increase in net revenues by $600 million or 5.5% year-over-year demonstrates the company's ability to navigate market challenges and capitalize on the growing demand for smoke-free alternatives.

However, the decline in reported EPS highlights the impact of non-cash adjustments, particularly related to fair value adjustments for equity security investments. This discrepancy suggests that while the operational performance is robust, external factors are affecting the bottom line.

Dividend and Shareholder Returns

PMI announced an increase in its regular quarterly dividend by 8.8% to $1.60 per share, translating to an annualized dividend of $6.40 per share. This increase reflects the company's commitment to returning value to shareholders, even amidst fluctuating earnings.

Forward Guidance and Catalysts

Looking ahead, investors should monitor PMI's performance in the fourth quarter, particularly in light of the company's guidance for continued growth in smoke-free products. The company anticipates a full-year adjusted diluted EPS forecast in the range of $8.29 to $8.44, which represents a projected increase of 9.9% to 11.9% compared to the previous year. This guidance is supported by expected organic revenue growth of 5% to 7% and operating income growth of 7% to 9%.

Additionally, PMI's ongoing investments in expanding its smoke-free product portfolio and the recent FDA authorizations for various ZYN products position the company well for future growth. Investors should keep an eye on the impact of geopolitical tensions and energy-related inflation, which could influence operational costs and margins in the upcoming quarters.

In summary, while the reported EPS decline may raise concerns, the underlying growth in adjusted EPS and revenue, coupled with a dividend increase, presents a favorable outlook for PMI's shareholders. The company's strategic focus on smoke-free products and robust market performance are key factors to watch as we move into the next quarter.

Condensed Consolidated Statements of Income (in millions)

Note: All amounts are in millions.

Condensed Consolidated Balance Sheets (in thousands)

Note: All amounts are in thousands.

Quarterly Earnings — Revenue vs. Estimate

Revenue vs. Estimate — 5 Quarters

EPS vs. Estimate — 5 Quarters

Analyst Ratings & Price Targets

Wall Street analysts have shown mixed sentiment toward Philip Morris International (PM) in recent months, with a blend of upgrades, downgrades, and initiations shaping the outlook. BTIG Research initiated coverage with a Buy rating and a $216 price target, while Jefferies downgraded the stock from Buy to Hold in January 2026, cutting its target to $180. Earlier, Jefferies had resumed coverage with a Buy rating and a $220 target in July 2025, and Needham initiated at Buy with a $195 target. UBS upgraded PM from Sell to Neutral in April 2025, raising its target to $170, and Argus lifted its rating from Hold to Buy in March 2025. The consensus price target suggests moderate upside potential from current levels, reflecting cautious optimism amid evolving regulatory and market conditions for the tobacco giant. Analysts appear divided, with recent moves signaling both confidence and tempered expectations.

Technical Analysis — 90-Day Price Chart

Philip Morris International Inc. (PM) trades at $197.46, sustaining an uptrend as the price remains above its key moving averages (SMA20: $195.55, SMA50: $190.85), with the SMA20 crossing above the SMA50 recently, reinforcing bullish momentum. The RSI(14) at 62.6 indicates neutral-to-moderate bullish momentum, avoiding overbought territory. Volume at 5.77M shares exceeds the 20-day average of 4.47M, supporting the recent price strength. Positioned at 78% of its 52-week range ($169.42–$210.45), PM faces near-term resistance near the $210.45 high, while the rising SMAs and the mid-range level around $190 provide support. The stock’s ability to hold above the SMA50 suggests sustained bullish sentiment, though a break below $190 could signal a reversal.